Texas Biotech (TXB) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DZOO who wrote (168)	5/6/1997 1:42:00 PM
From: Bill Tomko	of 834

The short answer is if they want to put a lable claim on then they need clinicals. However; in the real world once a product is approved for sale there is no restriction, other then medical malpractice, from using it for off lable indications. If it is seen as a heprin replacement with a good use profile and there is some medical lit. then it will be used wihtout a lable claim and clincials. The key issue for this product IMO is cost and safety profile. In most people heprin works well and is cheap. How much will incremtal benifits cost?? That is the question in my mind. This product will require IMO a lot of educational selling.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next